| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |